Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating BB-10901 in patients with relapsed or refractory multiple myelom…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of bortezomib, thalidomide, and dexamethasone in relapsed or refractory multiple myeloma; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Preventive Treatment of VETD in Patients With Multiple Myeloma Receiving Chemotherapy With Thalidomide or Lenalinomide.
A completed clinical trial evaluating preventive treatment for VETD in patients with multiple myeloma receiving thalidomide- or lenalidomide…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Studying Fentanyl in Patients With Cancer
A Johns Hopkins cancer center trial evaluating fentanyl in cancer patients has been terminated. The study encompassed multiple cancer-relate…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma [NA]
A completed clinical trial assesses the use of whole-body diffusion-weighted MRI in patients with multiple myeloma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma [Phase 2]
A Phase 2 clinical trial update evaluating chemotherapy plus bone marrow transplantation in patients with refractory non-Hodgkin lymphoma, H…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Bryostatin-1 was studied in patients with relapsed multiple myeloma. The Phase 2 study has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [Phase 2]
A phase 2 clinical trial evaluating a biological therapy after chemotherapy and peripheral stem cell transplantation in patients with variou…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [Phase 1, Phase 2]
This Phase 1/2 trial evaluates a combination chemotherapy regimen followed by peripheral stem cell transplantation in patients with refracto…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease [NA]
This completed clinical trial examines donor stem cell transplantation after conditioning therapy in patients with hematologic cancers, recu…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Sorafenib and Bortezomib in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 study to evaluate the combination of sorafenib and bortezomib in patients with advanced cancers, including refractory chronic lymp…
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma [Phase 1]
The update covers a Phase 1 study of ACE-041 in patients with advanced solid tumors and relapsed/refractory multiple myeloma. The trial stat…
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating SyB L-0501 for multiple myeloma was terminated. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma [Phase 2]
This update reports the completion of a Phase 2 study of canfosfamide in refractory or relapsed mantle cell lymphoma, B-cell lymphoma, and m…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating a human anti-ICAM-1 monoclonal antibody in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
This clinical trial update indicates the study NCT00602147, investigating genetic mutations related to mucositis in multiple myeloma patient…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: A Retreatment Study With Bortezomib for Multiple Myeloma
This clinical trial update reports a retreatment study of bortezomib for multiple myeloma, which has now been completed.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma [Phase 2]
This Phase 2 trial evaluated thalidomide, doxorubicin, and dexamethasone in patients with untreated stage II or stage III multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Sunitinib in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
This is a Phase 2 trial of sunitinib in relapsed multiple myeloma (Stage I–III). The study has completed and results were posted in March 20…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: CP-751,871 Treatment For Patients With Multiple Myeloma [Phase 1]
A Phase 1 trial of CP-751,871 in patients with multiple myeloma has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of AE-941 for relapsed or refractory Multiple Myeloma has been completed, reported by AEterna Zentaris.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating the combination of sorafenib and bortezomib in relapsed or refr…
-
CLINICAL_TRIALS trial_result · 2013-02-26Clinical Trial Update: Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine [EARLY_Phase 1]
This clinical trial update reports completion of an early-phase 1 study evaluating cyclophosphamide and pulse dexamethasone with either rapa…
-
CLINICAL_TRIALS trial_result · 2013-02-25Clinical Trial Update: Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
This document reports the completion and posting of results for a Phase 2 clinical trial evaluating dinaciclib in patients with relapsed or …
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS)
A regulatory post-marketing surveillance study of bortezomib (Velcade) in Korea has completed. The study focused on patients with multiple m…